Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -0.05% is 100% above its 4-year average of -69.29%, near the high end of its 4-year range (-214.61%–-0.05%).
As of the fiscal period ended Tuesday, June 30, 2026. 99.89% above its 12-month average of -48.65%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -0.05%.
RETURN ON INVESTED CAPITAL (ROIC)
-0.05%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-48.65%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-50.57%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+99.89%
CURRENT VS 3Y AVG
+99.90%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-32.63%
median of 626 covered companies
CURRENT VS SECTOR MEDIAN
+99.84%
vs the sector median at left
Coya Therapeutics, Inc.
Market Cap
$114.29M
Return on Invested Capital (ROIC)
-0.05%
TTM Avg
-48.65%
3Y Avg
-50.57%
5Y Avg
N/A
Market Cap
$114.08M
Return on Invested Capital (ROIC)
-19.83%
TTM Avg
-23.34%
3Y Avg
-19.01%
5Y Avg
-18.39%
Market Cap
$115.09M
Return on Invested Capital (ROIC)
-145.10%
TTM Avg
-158.49%
3Y Avg
-239.94%
5Y Avg
-201.97%
Market Cap
$113.02M
Return on Invested Capital (ROIC)
-44.81%
TTM Avg
-53.33%
3Y Avg
-46.90%
5Y Avg
-39.65%
Market Cap
$116.14M
Return on Invested Capital (ROIC)
-192.18%
TTM Avg
-186.03%
3Y Avg
-161.77%
5Y Avg
-220.86%
Market Cap
$116.54M
Return on Invested Capital (ROIC)
-87.72%
TTM Avg
-74.88%
3Y Avg
-52.32%
5Y Avg
-62.32%
Market Cap
$117.37M
Return on Invested Capital (ROIC)
-223.06%
TTM Avg
-221.51%
3Y Avg
-125.15%
5Y Avg
-99.68%
Market Cap
$111.14M
Return on Invested Capital (ROIC)
-3.19%
TTM Avg
-2.23%
3Y Avg
-1.75%
5Y Avg
1.24%
Market Cap
$110.10M
Return on Invested Capital (ROIC)
-352.19%
TTM Avg
-1462.52%
3Y Avg
-874.13%
5Y Avg
-711.22%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Coya Therapeutics, Inc. (COYA) | $114.29M | -0.05% | -48.65% | -50.57% | N/A |
| MaxCyte, Inc. (MXCT)vs › | $114.08M | -19.83% | -23.34% | -19.01% | -18.39% |
| Lucid Diagnostics Inc. (LUCD)vs › | $115.09M | -145.10% | -158.49% | -239.94% | -201.97% |
| Foghorn Therapeutics Inc. (FHTX)vs › | $113.02M | -44.81% | -53.33% | -46.90% | -39.65% |
| Genelux Corporation (GNLX)vs › | $116.14M | -192.18% | -186.03% | -161.77% | -220.86% |
| Caribou Biosciences, Inc. (CRBU)vs › | $116.54M | -87.72% | -74.88% | -52.32% | -62.32% |
| Insight Molecular Diagnostics Inc. (IMDX)vs › | $117.37M | -223.06% | -221.51% | -125.15% | -99.68% |
| BGM Group Ltd. (BGM)vs › | $111.14M | -3.19% | -2.23% | -1.75% | 1.24% |
| Outlook Therapeutics, Inc. (OTLK)vs › | $110.10M | -352.19% | -1462.52% | -874.13% | -711.22% |
| LENZ Therapeutics, Inc. (LENZ)vs › | $118.99M | -61.84% | -30.30% | -57.06% | -116.42% |
ROIC
-0.1%
ROE
-0.1%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -0.05% |
| 2026-03-31 | -44.25% |
| 2025-12-31 | -50.00% |
| 2025-09-30 | -70.80% |
| 2025-06-30 | -78.14% |
| 2025-03-31 | -57.08% |
| 2024-12-31 | -42.57% |
| 2024-09-30 | -34.17% |
| 2024-06-30 | -28.99% |
| 2024-03-31 | -31.71% |
| 2023-12-31 | -21.83% |
| 2023-09-30 | -116.19% |
| 2023-06-30 | -81.67% |
| 2023-03-31 | -68.17% |
| 2022-12-31 | -214.61% |
| 2022-09-30 | -144.99% |
| 2022-06-30 | -89.33% |
| 2022-03-31 | -153.69% |
| 2021-12-31 | -133.66% |
